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e.g. generalized or focal atrophy including neuronal loss and the obser-
vation of persistent stable performance in clinical tasks has led to the
hypothesis of functional compensation. Although characterization and
detailed understanding of the underlying mechanisms are of funda-
mental interest and may eventually lead to novel symptomatic thera-
peutic strategies in neurodegenerative diseases, only a few systematic
studies have addressed this topic so far (Scheller et al., 2014). This
probably originates from the fact that brain reserve capacity or compen-
sation mechanisms are difﬁcult to measure. These take place on a func-
tional level for example by activation of neuronal networks or as
transient task-dependent phenomena based on both individual as well
as disease speciﬁc structural prerequisites.
Klöppel and colleagues have addressed this fascinating topic and
present a new approach to visualize and characterize compensation in
preclinical HD gene carriers (preHD) (Klöppel et al., 2015). For this pur-
pose preHD subjects serve as ideal candidates since they have been
shown to remain asymptomatic for years even when using sophisticat-
ed cognitive tests or motor tasks. Volumetric brain imaging indicates
progressive neurodegeneration in these patients. The exact time point
of preHD converting into the clinical stage of the disease however is
poorly characterized and currently discussed (Bilgan et al., 2009;
Tabrizi et al., 2013).
Based on the assumption that compensation requires an enhanced
neuronal activation (Cabeza and Dennis, 2013; Quiroz et al., 2010) ac-
companied by an increased metabolism and blood ﬂow, Klöppel and
colleagues used resting state (rs-fMRI) and task related functional MRI
(fMRI) to investigate a comparatively large group of preHD gene car-
riers. To depict brain activity suspicious for compensation, they have
searched for positive correlations between brain areas showing a high
disease load as deﬁned by volumetric measures and signiﬁcant increase
in brain activity while detailed motor and cognitive tasks had to be per-
formed. Functional connectivity of certain brain areas in neuronal net-
works was investigated under resting state conditions.
Since no alternative method to reliably investigate compensation in
respect to area speciﬁc disease load has been established up to now, the
presented results will need further validation. In addition methodicalDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.08.002.
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the area speciﬁc disease load and choice of cognitive and motor tasks
especially for longitudinal investigations) will have to be discussed to
further optimize this proposed model of compensation. It has to be
emphasized that Klöppel et al. critically review these issues.
When discussing potential compensational mechanisms it has to be
considered that downregulation of neuronal activity or disengagement
of certain neuronal networks may as well reﬂect compensational pro-
cesses (Cox et al., 2015). Thus, results revealing negative correlations
between brain areas showing high disease load should not be ignored
but discussed with the same emphasis as results showing positive
correlations. Compensational remodeling takes place on a functional
level and is partly induced as a transient task dependent activation. It
represents a comparably unstable situation with changing pathways
and potential coexisting strategies. This particular aspect has to be
respected in the discussion of investigational results and should be an-
alyzed in longitudinal studies, although a group analysis using rs-fMRI
did not show signiﬁcant changes in functional connectivity in preHD
gene carriers over a period of 3 years (Odish et al., 2015).
Assuming that compensation in HD exists and that we soon will be
able to reliably monitor compensational processes a multitude of ques-
tions arise for further investigations. Compensation is discussed as a
substantial mechanism to prolong the preclinical phase not only in HD
mutant gene carriers but also in preclinical subjects at risk for other neu-
rodegenerative diseases as well. Thus, it would be of great interest to
study whether drugs or therapeutic interventions can initiate compen-
sational processes in order to delay symptomonset. Diseasemodulating
effects like environmental enrichment or cognitive interventions, which
have been shown to delay onset of symptoms inHD in this context, have
to be discussed as inﬂuencing factors (Kotloski and Sutula, 2015;
Andrews et al., 2015). Furthermore itwould be important to understand
whether compensation is restricted to the preclinical state in HD or if it
also can be observed and used therapeutically during the clinical course
of the disease as well. What are the essential structural and cellular
prerequisites that must be preserved so that neuronal networks can
be activated for functional remodeling? Can we identify the factors
that lead to the breakdown of compensational processes? Is it really
true that compensation is restricted to certain cognitive skills exclusive-
ly but is not found to stabilize other important systems like motor func-
tion? Is it really a characteristic of the right hemisphere as the results ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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be extended a lot.
Taken together, Klöppel and colleagues present an elaborate diag-
nostic tool to depict compensational processes in relation to area specif-
ic disease load. This model may well be suited as a fundamental
resource in characterizing and monitoring compensation mechanisms
in neurodegenerative diseases. This in turnmay lead to novel symptom-
atic therapies delaying onset of symptoms and decelerating disease
progression.
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